Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BTBD18 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | CEBPB | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | MYT1L | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | TOMM40 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | ZFP2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | C9orf57 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | PRKACG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | CLDN4 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.02 |
mRNA | BIRC5 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | C1orf168 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |